11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid has been researched along with naproxen in 1 studies
Studies (11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid) | Trials (11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid) | Recent Studies (post-2010) (11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid) | Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) |
---|---|---|---|---|---|
304 | 27 | 103 | 4,551 | 1,057 | 1,429 |
Protein | Taxonomy | 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid (IC50) | naproxen (IC50) |
---|---|---|---|
Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 1.1642 | |
Hormone-sensitive lipase | Rattus norvegicus (Norway rat) | 1.2 | |
Prostaglandin G/H synthase 1 | Homo sapiens (human) | 4.0203 | |
Prostaglandin G/H synthase 2 | Homo sapiens (human) | 3.8725 | |
Prostaglandin G/H synthase 2 | Rattus norvegicus (Norway rat) | 0.06 | |
Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 0.5867 | |
Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | 1.26 | |
Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 3.36 | |
Solute carrier family 22 member 6 | Homo sapiens (human) | 5.8 | |
Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | 0.06 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Audette, CA; Burstein, SH; Doyle, SA; Hull, K; Hunter, SA; Latham, V | 1 |
1 other study(ies) available for 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid and naproxen
Article | Year |
---|---|
Antagonism to the actions of platelet activating factor by a nonpsychoactive cannabinoid.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Cannabinoids; Dronabinol; Edema; Female; Hydroxyeicosatetraenoic Acids; Mice; Naproxen; Platelet Activating Factor; Structure-Activity Relationship | 1989 |